NEW YORK, Aug. 8, 2016 /PRNewswire/ -- The plasma therapy market is expected to grow from USD 135.6 million in 2016 to USD 297.6 million by 2021, at a CAGR of 14.0% from 2016 to 2021. This market is segmented on the basis of type, source, application, end user, and region. The pure PRP segment of the plasma therapy type market is expected to grow at the highest CAGR during the forecast period. Growth in this segment is mainly attributed to the high success rate of pure PRP therapy, less recovery time, and increase in healthcare expenditure worldwide.
Based on source, the plasma therapy market is segmented into autologous and allogenic. The autologous source segment is estimated to account for the largest share of the plasma therapy market in 2016. Prevalence of orthopedic disorders and the need for development of new therapies will drive the growth of this segment.
Based on application, the plasma therapy market is segmented into dermatology, cardiac muscle injury, dental, nerve injury, and others. The orthopedic segment is further segmented into arthritis, chronic tendinitis, and bone repair & regeneration. Similarly, the dermatology segment is further segmented into androgenic alopecia and plastic surgery. The dermatology application segment is expected to grow at the highest CAGR from 2016 to 2021, owing to increase in the number of cosmetic procedures and prevalence of dermatological disorders such as androgenic alopecia.
Based on end user, the plasma therapy market is segmented into hospitals & clinics and research institutes. The hospitals & clinics segment is estimated to account for the largest share of the global plasma therapy market in 2016. Rise in healthcare spending has resulted in the increasing use of PRP in hospitals & clinics.
On the basis of region, the plasma therapy market is led by North America, followed by Europe, Asia-Pacific, and rest of the world. Major factors contributing to the growth of the plasma therapy market include high incidences of trauma, increase in healthcare expenditure, and access to medical insurance in the U.S. On the other hand, stringent regulatory policies and side-effects associated with PRP therapy are restraining the growth of this market.
The report provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. In addition to this, the report also offers an overview of company profiles that comprise product portfolios, developments, and strategies adopted by market players to maintain and increase their shares in the market. The market research data, current market size, and forecast of the future trends will help key market players and new entrants to make necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to maintain their competitive position in the plasma therapy market.
Major players operating in the plasma therapy market include BioLife Plasma Services (U.S.), Cambryn Biologics LLC (U.S.), Biotest (Germany), CSL Ltd. (Australia), Grifols International S.A. (Spain), Kedrion S.p.A. (Italy), LFB (France), Bio Products Laboratory Ltd. (BPL) (U.K.), China Biologic Products, Inc. (China), and Octapharma (Switzerland).
Reasons to Buy the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below mentioned strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on product portfolios of top players in the plasma therapy market. The report analyzes the plasma therapy market on the basis of type, source, application, end user, and region.
- Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the plasma therapy market.
- Competitive Assessment: In-depth assessment of market strategies, geographic and business segments, and product portfolios of leading players in the plasma therapy market.
- Market Development: Comprehensive information about emerging markets; this report analyzes the market for various plasma therapy products across varied geographies.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the plasma therapy market.
Read the full report: http://www.reportlinker.com/p04010940-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/plasma-therapy-market-by-type-source-application-end-user-region---global-forecast-to-2021-300310729.html